Impact of obstructive sleep apnea on cognitive and motor functions in Parkinson's disease

M Elfil, EI Bahbah, MM Attia, M Eldokmak… - Movement …, 2021 - Wiley Online Library
Introduction Parkinson's disease (PD) is a chronic neurodegenerative disorder that presents
with motor and non‐motor manifestations. Amongst the non‐motor features, various forms of …

Nanomedicines, an emerging therapeutic regimen for treatment of ischemic cerebral stroke: A review

W Chen, L Jiang, Y Hu, G Fang, B Yang, J Li… - Journal of Controlled …, 2021 - Elsevier
Owing to its intricate pathophysiology, cerebral stroke is a serious medical condition caused
by interruption or obstruction of blood supply (blockage of vasculature) to the brain tissues …

Stroke in Parkinson's disease: a review of epidemiological studies and potential pathophysiological mechanisms

M Elfil, A Bayoumi, A Sayed, M Aladawi… - Acta Neurologica …, 2023 - Springer
Parkinson's disease (PD) is the fastest growing neurological disorder and one of the leading
neurological causes of disability worldwide following stroke. An overall aging global …

Identifying patients with acute ischemic stroke within a 6-h window for the treatment of endovascular thrombectomy using deep learning and perfusion imaging

H Gao, Y Bian, G Cheng, H Yu, Y Cao, H Zhang… - Frontiers in …, 2023 - frontiersin.org
Introduction It is critical to identify the stroke onset time of patients with acute ischemic stroke
(AIS) for the treatment of endovascular thrombectomy (EVT). However, it is challenging to …

A multicenter diagnostic accuracy study on prehospital stroke screening scales

P Saberian, H Rafiemanesh, F Heydari… - Archives of Iranian …, 2021 - journalaim.com
Background: Stroke is one of the most common debilitating diseases. Although effective
treatment is available, a golden time has been defined in this regard. Therefore, prompt …

Emerging paradigms in treating cerebral infarction with nanotheranostics: opportunities and clinical challenges

WH Almalki, S Alghamdi, A Alzahrani, W Zhang - Drug Discovery Today, 2021 - Elsevier
Cerebral infarction (stroke) is a fatal disease owing to blockage of the brain blood vessels.
Although it is often considered a disease of old age, unhealthy diets, stressful lifestyles, and …

Dual antiplatelet therapy versus intravenous tissue plasminogen activator with acute minor ischemic stroke: A systematic review and meta-analysis of safety and …

A Abbas, AA Hamad, MHED Moawad, DK Ewis… - Journal of Stroke and …, 2024 - Elsevier
Objectives To compare the safety and efficacy of Dual Antiplatelet Therapy (DAPT) and
Intravenous (IV) Tissue Plasminogen Activator (t-PA) in Acute minor Ischemic Stroke (AIS) …

Nanomedicine in Management of Cerebral Infarction and Brain Cancer: Role of Inflammation

V Kumar, FA Abbasi, F Anwar… - Current Medicinal …, 2024 - benthamdirect.com
Introduction Cerebral infarction, the blockage of blood vessels in the brain, is generally an
age-related illness. Factors such as unhealthy diets, stressful behaviours and decreased …

Efficacy and safety of rt-PA intravenous thrombolysis in patients with wake-up stroke: A meta-analysis

H Liu, W Hu, F Zhang, W Gu, J Hong, J Chen, Y Huang… - Medicine, 2022 - journals.lww.com
Background: Recombinant tissue plasminogen activator (rt-PA) is one of the most effective
therapies for patients with acute ischemic stroke. However, wake-up stroke (WUS) is …

Stroke: What's Sleep Got to Do With It?

A Zafar, P Dhruv, A Anwar… - Journal of Clinical …, 2022 - journals.lww.com
Ischemic strokes most often occur between 6 am and 12 am after awakening from sleep but
up to 30% occur during sleep. Wake-up strokes (WUS) are new focal neurological deficit (s) …